PsychoPharmacology News

By Circle Of Insight ProductionsBusiness Science Social Sciences Medicine Health & Fitness

PsychoPharmacology News episodes

November 02 The Pharmacology of Study Drugs: Amphetamines, Dopamine, and Cognitive Enhancement
Explore how amphetamine-based medications influence dopamine and norepinephrine signaling, why subjective concentration can differ from measurable cognitive improvement, and how dose and sleep deprivation influence outcomes.
3 min
November 01 Withdrawal or Relapse? Why Antidepressant Discontinuation Can Be Misunderstood
Explore the psychological and clinical challenges of distinguishing antidepressant discontinuation symptoms from the return of depression or anxiety. Examine how symptom timing, physical sensations, and emotional changes influence clinical assessment, and why a careful medication history is essential.
5 min
October 27 When Addiction Treatment Becomes Addiction Maintenance: The Pharmacology Behind Rehab Fraud
What happens when a facility entrusted with treating substance-use disorders allegedly helps perpetuate the very addiction it promises to address? This episode examines the neurobiology of opioid and stimulant dependence, withdrawal, craving, and the medications used in evidence-based addiction treatment. We explore how access to drugs, inadequate medical supervision, and repeated treatment disruptions can undermine recovery. The Southern California rehab fraud allegations provide a disturbing backdrop for understanding the difference between legitimate pharmacological treatment and exploiting addiction for financial gain.
3 min
October 26 SSRIs Compared: Best Diagnoses, Half-Lives, Side Effects, and Prescribing Exceptions
Not every SSRI is interchangeable — choosing the right one depends on far more than just the diagnosis in front of you. This episode compares seven SSRIs across their FDA-approved indications for depression, OCD, panic disorder, and generalized anxiety disorder, breaking down half-lives, side-effect profiles, and the prescribing nuances that separate one agent from another. We cover pediatric and geriatric precautions, key drug interactions, discontinuation syndrome, and the risk of serotonin toxicity. Built for PMHNP board prep, this episode walks through how to distinguish these medications in real clinical scenarios and match treatment to patient presentation.
6 min
October 26 Dopamine Blockade: Why Antipsychotics Work and Why They Cause Side Effects
Antipsychotic medications frequently act on dopamine D2 receptors, but blocking these receptors produces different effects depending on where they are located in the brain. This episode examines how dopamine antagonism and partial agonism influence psychotic symptoms, movement disorders, and prolactin secretion. We compare first-generation and second-generation antipsychotics, including haloperidol, risperidone, aripiprazole, and clozapine. The discussion explains why understanding receptor pharmacology is essential for balancing therapeutic benefits against adverse effects.
5 min
October 21 Why Prozac, Zoloft, and Lexapro Affect Patients Differently
Explore pharmacokinetics, CYP450 metabolism, serotonin transporter inhibition, and receptor adaptations. Explain why medications within the same class can differ in tolerability and interaction potential.
7 min
October 20 Why Antidepressants Take Weeks to Work
Explore serotonin transporters, receptor adaptations, and the differences between immediate medication effects and delayed clinical improvement. Explain why antidepressant response cannot be reduced to a simple chemical imbalance.
5 min
October 19 Methamphetamine vs. Adderall: How Different Are They Really?
Methamphetamine and prescription amphetamines share important pharmacological properties, but differences in chemical structure, dosing, delivery, and medical supervision can profoundly affect their risks. This episode compares methamphetamine, Adderall, and Ritalin through the lens of neurotransmitter activity and clinical pharmacology. We also explore why methamphetamine itself retains a limited legitimate medical role despite its association with severe addiction.
5 min
October 18 Why Antidepressants Take Weeks to Work
Explore serotonin transporters, receptor adaptations, and the differences between immediate medication effects and delayed clinical improvement. Explain why antidepressant response cannot be reduced to a simple chemical imbalance.
5 min
October 15 Beyond Fentanyl: The Rise of Synthetic Opioids Ten Times More Potent
A new class of synthetic opioids known as orphine analogues has been detected in illicit drug supplies across 22 American states, raising concerns about the next evolution of the opioid crisis. Some of these compounds have demonstrated pharmacological potency substantially greater than fentanyl, while conventional drug screening methods may fail to identify them. We examine how these substances affect the brain, why respiratory depression is so dangerous, and what makes their detection and treatment particularly challenging. We also explore the implications for emergency medicine, forensic toxicology, and the future of opioid pharmacology.
4 min

About PsychoPharmacology News

From the publisher's feed

Psychopharmacology: Drugs, the Brain & Behavior explores what medications actually do to the brain—and what the research really says about their benefits, risks, controversies, and unexpected…